Use of Sofosbuvir-Based Direct-Acting Antiviral Therapy for Hepatitis C Viral Infection in Patients with Severe Renal Insufficiency

Sofosbuvir-based direct-acting antiviral therapy revolutionized the treatment of hepatitis C virus (HCV) infection; however, sofosbuvir use is not approved for patients with severe renal insufficiency [estimated glomerular filtration (eGFR) rate below 30 mL/min] or end stage renal disease (ESRD) bas...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Infect Dis (Lond)
Auteurs principaux: Hundemer, Gregory L., Sise, Meghan E., Wisocky, Jessica, Ufere, Nneka, Friedman, Lawrence S., Corey, Kathleen E., Chung, Raymond T.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4732277/
https://ncbi.nlm.nih.gov/pubmed/26365684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/23744235.2015.1078908
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires